Home > Research > Publications & Outputs > The ambivalence of radiotherapy

Links

Text available via DOI:

View graph of relations

The ambivalence of radiotherapy: Re-framing effects and their temporalities in treatment for gynaecological cancer

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

The ambivalence of radiotherapy: Re-framing effects and their temporalities in treatment for gynaecological cancer. / Kragh-Furbo, Mette; Hutton, Daniel; Stewart, Hilary et al.
In: Social Science & Medicine, 08.2023.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

APA

Vancouver

Author

Bibtex

@article{9498323d3cba4d4d926c0a8f1ca16bbc,
title = "The ambivalence of radiotherapy: Re-framing effects and their temporalities in treatment for gynaecological cancer",
abstract = "Within the biomedical paradigm, treatment effects are typically split into primary and secondary effects with temporality playing a key role in this separation. Yet, this kind of ordering of effects with some effects understood as happening on the {\textquoteleft}side{\textquoteright}, secondary and temporary, does not fit with how they are experienced by many patients who undergo treatment for cancer. Drawing on empirical data from a research project that gathered narratives of women's experiences of radiotherapy for gynaecological cancer, we observe radiotherapeutic effects that are experienced as ambivalent and temporally diverse and as overlapping demands that the women endure and manage. We propose Derrida's concept of pharmakon as a relevant and useful analytic for understanding radiotherapy treatment, thus bringing into focus the ambivalent effects of radiotherapy - it is both therapeutic and toxic. Pharmakon, we argue, offers a way of disrupting the logics that govern current practices of therapeutic radiotherapy, and provides a way to re-negotiate the ordering and temporal understandings and practices of therapeutic efficacy, outcome and accountability of radiotherapy treatment - away from a temporal fragmentation of treatment effects and patients' bodily experiences to a focus on how best to support the whole patient in living with the ambivalent, temporally diverse and overlapping effects and demands of treatment.",
keywords = "Ambivalence, Side effects, Gynae cancer, Lived experience, Radiotherapy treatment",
author = "Mette Kragh-Furbo and Daniel Hutton and Hilary Stewart and Lisa Ashmore and Vicky Singleton",
year = "2023",
month = aug,
doi = "10.1016/j.socscimed.2023.116183",
language = "English",
journal = "Social Science & Medicine",
issn = "0277-9536",
publisher = "Elsevier Limited",

}

RIS

TY - JOUR

T1 - The ambivalence of radiotherapy

T2 - Re-framing effects and their temporalities in treatment for gynaecological cancer

AU - Kragh-Furbo, Mette

AU - Hutton, Daniel

AU - Stewart, Hilary

AU - Ashmore, Lisa

AU - Singleton, Vicky

PY - 2023/8

Y1 - 2023/8

N2 - Within the biomedical paradigm, treatment effects are typically split into primary and secondary effects with temporality playing a key role in this separation. Yet, this kind of ordering of effects with some effects understood as happening on the ‘side’, secondary and temporary, does not fit with how they are experienced by many patients who undergo treatment for cancer. Drawing on empirical data from a research project that gathered narratives of women's experiences of radiotherapy for gynaecological cancer, we observe radiotherapeutic effects that are experienced as ambivalent and temporally diverse and as overlapping demands that the women endure and manage. We propose Derrida's concept of pharmakon as a relevant and useful analytic for understanding radiotherapy treatment, thus bringing into focus the ambivalent effects of radiotherapy - it is both therapeutic and toxic. Pharmakon, we argue, offers a way of disrupting the logics that govern current practices of therapeutic radiotherapy, and provides a way to re-negotiate the ordering and temporal understandings and practices of therapeutic efficacy, outcome and accountability of radiotherapy treatment - away from a temporal fragmentation of treatment effects and patients' bodily experiences to a focus on how best to support the whole patient in living with the ambivalent, temporally diverse and overlapping effects and demands of treatment.

AB - Within the biomedical paradigm, treatment effects are typically split into primary and secondary effects with temporality playing a key role in this separation. Yet, this kind of ordering of effects with some effects understood as happening on the ‘side’, secondary and temporary, does not fit with how they are experienced by many patients who undergo treatment for cancer. Drawing on empirical data from a research project that gathered narratives of women's experiences of radiotherapy for gynaecological cancer, we observe radiotherapeutic effects that are experienced as ambivalent and temporally diverse and as overlapping demands that the women endure and manage. We propose Derrida's concept of pharmakon as a relevant and useful analytic for understanding radiotherapy treatment, thus bringing into focus the ambivalent effects of radiotherapy - it is both therapeutic and toxic. Pharmakon, we argue, offers a way of disrupting the logics that govern current practices of therapeutic radiotherapy, and provides a way to re-negotiate the ordering and temporal understandings and practices of therapeutic efficacy, outcome and accountability of radiotherapy treatment - away from a temporal fragmentation of treatment effects and patients' bodily experiences to a focus on how best to support the whole patient in living with the ambivalent, temporally diverse and overlapping effects and demands of treatment.

KW - Ambivalence

KW - Side effects

KW - Gynae cancer

KW - Lived experience

KW - Radiotherapy treatment

U2 - 10.1016/j.socscimed.2023.116183

DO - 10.1016/j.socscimed.2023.116183

M3 - Journal article

JO - Social Science & Medicine

JF - Social Science & Medicine

SN - 0277-9536

M1 - 116183

ER -